Is Mesa Laboratories, Inc. technically bullish or bearish?
2025-09-20 19:04:09As of 1 July 2025, the technical trend for Mesa Laboratories, Inc. has changed from mildly bearish to bearish. The current stance is bearish with a strong indication from multiple indicators: the MACD is bearish on both weekly and monthly time frames, moving averages are bearish on a daily basis, and the KST is bearish across both weekly and monthly periods. Additionally, Bollinger Bands and OBV show mildly bearish signals. The Dow Theory indicates a mildly bearish trend on the weekly chart, while the monthly chart shows no trend. In terms of performance, the stock has significantly underperformed against the S&P 500, with a year-to-date return of -47.55% compared to the S&P 500's 12.22%, and a one-year return of -45.17% versus 17.14% for the benchmark....
Read MoreIs Mesa Laboratories, Inc. overvalued or undervalued?
2025-09-20 17:37:44As of 5 June 2024, Mesa Laboratories, Inc. has moved from a fair to risky valuation grade. The company appears to be overvalued, particularly given its significant losses reflected in the P/E ratio, which is not applicable due to the loss-making status. Key ratios include a Price to Book Value of 3.55, an EV to EBITDA of 17.66, and an EV to Sales of 2.99, all indicating a high valuation relative to its financial performance. In comparison to peers, Mesa Laboratories has a notably high EV to EBITDA ratio compared to Atrion Corp. at 26.22, and a significantly worse P/E ratio than Silk Road Medical, Inc. at -19.76. The company's recent stock performance has been poor, with a year-to-date return of -47.55%, contrasting sharply with the S&P 500's positive return of 12.22% over the same period, further reinforcing the overvaluation narrative....
Read More





